XMD17-109 50 mg | Purity Not Available
TargetMol
XMD17-109 is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
More Information Supplier PageXMD17-109
Search Results
XMD17-109 2 mg | Purity Not Available
TargetMol
XMD17-109 is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
More Information Supplier PageXMD17-109
Atglistatin 25 mg | 99.81%
TargetMol
Atglistatin is a highly effective, specific and competitive ATGL inhibitor with an IC50 of ~0.7 μM for inhibition of lipolysis in vitro, and no toxicity when the concentration up to 50 μM.
More Information Supplier PageAtglistatin
Atglistatin 50 mg | 99.81%
TargetMol
Atglistatin is a highly effective, specific and competitive ATGL inhibitor with an IC50 of ~0.7 μM for inhibition of lipolysis in vitro, and no toxicity when the concentration up to 50 μM.
More Information Supplier PageAtglistatin
Des(benzylpyridyl) Atazanavi 50 mg | 98.00%
TargetMol
The N-dealkylated metabolite (M1) of Atazanavir, a HIV protease inhibitor.
More Information Supplier PageDes(benzylpyridyl) Atazanavi
Des(benzylpyridyl) Atazanavi 25 mg | 98.00%
TargetMol
The N-dealkylated metabolite (M1) of Atazanavir, a HIV protease inhibitor.
More Information Supplier PageDes(benzylpyridyl) Atazanavi
Des(benzylpyridyl) Atazanavi 10 mg | 98.00%
TargetMol
The N-dealkylated metabolite (M1) of Atazanavir, a HIV protease inhibitor.
More Information Supplier PageDes(benzylpyridyl) Atazanavi
Kobe0065 50 mg | 100.00%
TargetMol
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki value of 46 ± 13 μM.
More Information Supplier PageKobe0065
Kobe0065 25 mg | 100.00%
TargetMol
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki value of 46 ± 13 μM.
More Information Supplier PageKobe0065
Kobe0065 10 mg | 100.00%
TargetMol
Kobe0065 is a novel and effective small-molecule compound inhibiting Ras–Raf interaction by SBDD; shows potent activity to competitively inhibit the binding of H-Ras·GTP to c-Raf-1 RBD with a Ki value of 46 ± 13 μM.
More Information Supplier PageKobe0065